QBiotics wins FDA orphan status for rainforest-derived cancer drug
Though the designation is for soft tissue sarcoma, tigilanol tiglate is in clinical trials for multiple cancer types.
Though the designation is for soft tissue sarcoma, tigilanol tiglate is in clinical trials for multiple cancer types.
What's Your Reaction?
